Stock screenerAll disclosures →
EDGAR →
ANAB
Conviction 14HealthcareScan · Thu, Sep 24, 2026Bullish belt hold
Anaptysbio, Inc (ANAB) closed at $51.71 (+1.85%) on Sep 24, 2026. Its latest daily candle is a bullish belt hold. Price is below its 50-day and below its 200-day moving average. RSI(14) 37, RS Rating 96, -26.4% from its 52-week high, +15.0% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.
ANAB$51.71+1.85%
ResistanceSupportVol 14Vol MA14 582.35K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Price51.71
Change+1.85%
Gap-1.14%
Rel volume1.08×
Avg volume546.99K
Avg $ vol30.12M
SMA 2055.10
SMA 5055.47
SMA 20056.32
Price vs 50-6.77%
Price vs 200-8.18%
MA stackbearish
50/200 crossdeath · 3d
Supertrenddown · 59.02
RSI (14)37
MACD hist-0.38
MACD cross—
Stoch %K / %D24 / 26
ADX (14)22
+DI / −DI8 / 23
RSI divergence—
MACD divergence—
ATR %5.12%
ADR %4.56%
52w high70.22
52w low22.04
From 52w high-26.36%
Above 52w low+134.62%
New 52w highNo
SqueezeOn · 21d
Bollinger width12.21%
%B-0.00
Donchian pos24.25%
Donchian high58.77
Donchian low49.45
AVWAP (52w high)58.82
vs AVWAP high-12.08%
AVWAP (52w low)52.23
vs AVWAP low-1.00%
OBV trendDown
Chaikin MF (20)-0.11
Today vs 20d1.08×
Avg vol (14d)582.35K
Avg vol (20d)546.99K
Avg $ vol (20d)30.12M
Market cap1.55B
RS Rating96 / 99
RS 3m (vs SPY)-17.85%
RS 6m (vs SPY)-37.74%
RS line new highNo
Trend template3/8
Technical rank21.7
1 week-6.08%
1 month-11.41%
3 months-13.35%
6 months-20.92%
1 year+146.83%
YTD+15.04%
P/E-116.83
P/B121.27
P/S6.59
P/FCF78.83
EPS-0.4600
Div yield—
ROE-103.80%
ROA-4.01%
Debt/Eq—
Current7.58
EV/EBITDA26.78
Gross margin—
Net margin-5.64%
Rev growth157.01%
EPS growth90.89%
Price target84.00
Target upside62.44%
Analyst ratingBuy
Institutional107.17%
Ent. value1.3B
Revenue25.56M
Net income-52.88M
Gross profit—
Free cash flow19.61M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out29.1M
Employees104
ListedThu, Jan 26, 2017
Free float17.05M
Float %61.6%
Short interest5.41M
Days to cover15.6d
Short volume46.1%
Squeeze score70 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.11 vs −$0.46
Last surprise+76.1% beat
Setup gradeD
Conviction14 / 100
Pattern quality—
Tech rank21.7 / 100
Group rank59 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBullish belt hold
Financials as of Tue, Mar 31, 2026 · quarterly.
Recent news
- AnaptysBio (ANAB) Flags Positive AZUR 1 Data With Approval And Legal Timelinessimplywall.st · Wed, Sep 23, 2026
- Bank of America Corp DE Makes New $28.20 Million Investment in AnaptysBio, Inc. $ANABMarketBeat · Wed, Sep 23, 2026
- AnaptysBio, Inc. (NASDAQ:ANAB) Given Average Recommendation of "Moderate Buy" by AnalystsMarketBeat · Wed, Sep 23, 2026
- AnaptysBio (NASDAQ:ANAB) Shares Down 6.2% - What's Next?MarketBeat · Tue, Sep 22, 2026
- Why is AnaptysBio stock rising afterhours today?Investing.com · Tue, Sep 22, 2026
- Why is AnaptysBio stock rising afterhours today? By Investing.comInvesting.com Canada · Tue, Sep 22, 2026
- AnaptysBio, Inc. (ANAB) Reports Q2 Loss, Tops Revenue EstimatesYahoo Finance · Mon, Sep 21, 2026
- Spin-off leaves AnaptysBio (ANAB) a lean royalty firmStock Titan · Mon, Sep 21, 2026
- ANAPTYSBIO, INC: 8-K filedSEC EDGAR · Mon, Sep 21, 2026
Congress activity
Disclosed STOCK Act trades in ANAB
No recent disclosed trades by Congress in ANAB. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in ANAB
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Orwin John A Director · Common Stock · 2026-09-15 | Exercise | 1.3K | — | 2026-09-15 | 2026-09-17 |
Orwin John A Director · Restricted Stock Unit · 2026-09-15 | Exercise | 1.3K | — | 2026-09-15 | 2026-09-17 |
Faga Daniel President, CEO · Performance Stock Units · 2026-03-12 | Grant | 53.33K | — | 2026-03-12 | 2026-08-07 |
Lizzul Paul F. Chief Medical Officer · Performance Stock Units · 2026-03-12 | Grant | 16.67K | — | 2026-03-12 | 2026-08-07 |
RENTON HOLLINGS Director · Common Stock · 2026-06-15 | Exercise | 6.03K | — | 2026-06-15 | 2026-06-17 |
RENTON HOLLINGS Director · Restricted Stock Unit · 2026-06-15 | Exercise | 6.03K | — | 2026-06-15 | 2026-06-17 |
Orwin John A Director · Common Stock · 2026-06-15 | Exercise | 6.03K | — | 2026-06-15 | 2026-06-17 |
Orwin John A Director · Restricted Stock Unit · 2026-06-15 | Exercise | 6.03K | — | 2026-06-15 | 2026-06-17 |
Schmid John P. Director · Common Stock · 2026-06-15 | Exercise | 6.03K | — | 2026-06-15 | 2026-06-17 |
Schmid John P. Director · Restricted Stock Unit · 2026-06-15 | Exercise | 6.03K | — | 2026-06-15 | 2026-06-17 |
SEC filings
EDGAR filings in ANAB · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.